Galenica Sustainability and Business Performance
About Galenica
Market environment
Business performance
Governance
Sustainability
Outlook
Performance overview Galenica Group
History of resilient growth and margin improvement
Logistics, HealthCare
Information & Retail1
2012-2021 CAGRS
Retail market sales²
2.7%
Galenica net sales
4.1%
Galenica EBIT3
9.7% 1
Source:
1
2
3
08/08/22
Galenica
EBIT margin
3'480
3'835
3'301
6.0%
3'141
3'165
3'009
2'915
2'766
2'826
2'661
3.0%
0.0%
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Net sales (CHFm)
EBIT margin %
Company information, Galenica Annual Reports, IQVIA (former IMS Health)
Business segments were newly defined in 2014, the financial information until 2013 does not include Products&Brands
Retail market sales include direct and indirect pharmaceutical sales through pharmacies, self-dispensing doctors and drugstores (IQVIA Market Prognosis 2021-2025, Switzerland, published March 2021)
2014-16 reported EBIT, 2017-2021 adjusted EBIT (excluding IAS 19 impact and effects of IFRS 16 leasing (since 2019))
42
GALENICAView entire presentation